Swedish Orphan Biovitrum AB (publ)

OM:SOBI Stock Report

Market Cap: SEK 106.7b

Swedish Orphan Biovitrum Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OM:SOBI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Aug 24BuySEK 10,229,100Guido OelkersIndividual70,000SEK 146.13
30 Aug 24BuySEK 12,351,785Torbjörn HallbergIndividual84,526SEK 146.13
30 Aug 24SellSEK 86,013Katy MazibukoIndividual269SEK 319.75
30 Aug 24SellSEK 480,000Katy MazibukoIndividual1,500SEK 320.00
28 Aug 24SellSEK 21,936,899Guido OelkersIndividual70,000SEK 313.39
28 Aug 24SellSEK 26,952,806Torbjörn HallbergIndividual84,526SEK 318.87
27 Aug 24SellSEK 29,661,776Henrik StenqvistIndividual96,111SEK 308.62
27 Aug 24SellSEK 31,166,947Guido OelkersIndividual100,000SEK 311.67
27 Aug 24SellSEK 6,432,154Armin ReiningerIndividual20,452SEK 314.50
27 Aug 24SellSEK 21,436,230Daniel RankinIndividual68,535SEK 313.60
12 Aug 24BuySEK 23,392Katy MazibukoIndividual86SEK 272.00
26 Jul 24BuySEK 14,613,000Guido OelkersIndividual100,000SEK 146.13
25 Jul 24SellSEK 58,550,426Guido OelkersIndividual200,000SEK 293.08
25 Jul 24SellSEK 16,167,807Christine WesstromIndividual55,250SEK 292.63
23 Jun 24SellSEK 24,614,235Mahmood LadhaIndividual84,585SEK 291.00
04 Jun 24SellSEK 37,437,707Duane BarnesIndividual132,401SEK 282.76
04 Jun 24SellSEK 23,451,131Armin ReiningerIndividual83,219SEK 281.80
29 May 24SellSEK 30,270,883Guido OelkersIndividual110,000SEK 275.19
28 May 24SellSEK 30,330,200Guido OelkersIndividual110,000SEK 275.73
08 May 24BuySEK 10,078,512Daniel RankinIndividual49,344SEK 204.25
08 May 24SellSEK 16,422,862Daniel RankinIndividual58,480SEK 283.07

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SOBI?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders743,1640.216%
General Public32,813,0959.55%
VC/PE Firms122,964,76035.8%
Institutions186,914,81754.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 86.14% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
35.8%
Investor AB (publ)
122,964,760SEK 38.2b0%5.64%
10.2%
Morgan Stanley, Investment Banking and Brokerage Investments
35,043,624SEK 10.9b0%0.11%
6.12%
Fourth Swedish National Pension Fund (AP4)
21,010,927SEK 6.5b0%2.5%
4.64%
State Street Global Advisors, Inc.
15,937,784SEK 5.0b0%0.02%
3.69%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
12,656,839SEK 3.9b0%0.09%
3.01%
Swedbank Robur Fonder AB
10,332,683SEK 3.2b0%0.19%
2.59%
BNY Asset Management
8,889,547SEK 2.8b0%0.05%
2.54%
Polar Capital Holdings Plc
8,727,139SEK 2.7b0%0.88%
2.46%
AMF Fonder AB
8,431,488SEK 2.6b0%0.68%
2.25%
Handelsbanken Asset Management
7,717,648SEK 2.4b0%0.32%
2.1%
The Vanguard Group, Inc.
7,209,031SEK 2.2b-0.02%no data
1.67%
BlackRock, Inc.
5,729,078SEK 1.8b-5.03%no data
1.38%
Norges Bank Investment Management
4,725,721SEK 1.5b0%0.01%
1.02%
Carnegie Fonder AB
3,496,030SEK 1.1b37.5%0.99%
0.96%
Artisan Partners Limited Partnership
3,296,034SEK 1.0b0%0.07%
0.77%
Nordea Investment Management, AB
2,653,574SEK 824.2m0%0.05%
0.75%
Cliens Kapitalförvaltning AB
2,586,857SEK 803.5m0%2.37%
0.75%
SEB Investment Management AB
2,585,402SEK 803.0m0%0.14%
0.73%
Lansforsakringar Fondforvaltning AB
2,515,360SEK 781.3m0%0.26%
0.67%
E. Öhman J:or Wealth Management
2,306,031SEK 716.3m0%0.44%
0.63%
Forsta AP-fonden
2,156,703SEK 669.9m0%0.23%
0.39%
Geode Capital Management, LLC
1,325,346SEK 411.7m0.03%no data
0.37%
Storebrand Fonder AB,
1,270,236SEK 394.5m0%0.12%
0.34%
Tredje AP-fonden
1,158,786SEK 359.9m0%0.15%
0.32%
Skandia Fonder AB
1,097,716SEK 341.0m0%0.27%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 20:35
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Swedish Orphan Biovitrum AB (publ) is covered by 29 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alexander LindströmABG Sundal Collier
Rosie TurnerBarclays
Brian BalchinBarclays